Subcutaneous terbutaline as an alternative to aerosolized albuterol
- PMID: 32336646
- PMCID: PMC7167581
- DOI: 10.1016/j.jaip.2020.04.015
Subcutaneous terbutaline as an alternative to aerosolized albuterol
Comment in
-
Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol".J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2450-2452. doi: 10.1016/j.jaip.2020.04.016. Epub 2020 Apr 22. J Allergy Clin Immunol Pract. 2020. PMID: 32340824 Free PMC article. No abstract available.
Comment on
-
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.J Allergy Clin Immunol Pract. 2020 May;8(5):1477-1488.e5. doi: 10.1016/j.jaip.2020.03.012. Epub 2020 Mar 26. J Allergy Clin Immunol Pract. 2020. PMID: 32224232 Free PMC article. Review.
References
-
- Global Initiative for Asthma 2019 GINA Report, Global Strategy for Asthma Management and Prevention; 2019. https://ginasthma.org Available from: Accessed April 3, 2020.
-
- CMAJ Transmission of coronavirus by nebulizer—a serious, underappreciated risk! https://www.cmaj.ca/content/re-transmission-corona-virus-nebulizer-serio... Available from: Accessed April 3, 2020. - PMC - PubMed
-
- Strauss R.A., Jawhari N. The treatment of asthma exacerbations with subcutaneous terbutaline. J Allergy Clin Immunol. 2020;145:AB18. 054 (Abstract)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical